J Gen Virol 86 (2005), 197-210; DOI 10.1099/vir.0.80424-0
© 2005 Society for General Microbiology
Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate
C.-K. Lee1,
,
,
K. Kono1,
,
E. Haas2,
K.-S. Kim1,
K. M. Drescher3,
N. M. Chapman1 and
S. Tracy1
1 Enterovirus Research Laboratory, Department of Pathology and Microbiology, University of Nebraska Medical Center, 986495 Nebraska Medical Center, Omaha, NE 68198, USA
2 Department of Pathology and Microbiology, University of Nebraska Medical Center, 986495 Nebraska Medical Center, Omaha, NE 68198, USA
3 Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, NE 68178, USA
Correspondence
S. Tracy
stracy{at}unmc.edu
Group B coxsackieviruses (CVB) cause numerous diseases, including myocarditis, pancreatitis, aseptic meningitis and possibly type 1 diabetes. To date, infectious cDNA copies of CVB type 3 (CVB3) genomes have all been derived from pathogenic virus strains. An infectious cDNA copy of the well-characterized, non-pathogenic CVB3 strain GA genome was cloned in order to facilitate mapping of the CVB genes that influence expression of a virulence phenotype. Comparison of the sequence of the parental CVB3/GA population, derived by direct RT-PCR-mediated sequence analysis, to that of the infectious CVB3/GA progeny genome demonstrated that an authentic copy was cloned; numerous differences were observed in coding and non-coding sequences relative to other CVB3 strains. Progeny CVB3/GA replicated similarly to the parental strain in three different cell cultures and was avirulent when inoculated into mice, causing neither pancreatitis nor myocarditis. Inoculation of mice with CVB3/GA protected mice completely against myocarditis and pancreatitis induced by cardiovirulent CVB3 challenge. The secondary structure predicted for the CVB3/GA domain II, a region within the 5' non-translated region that is implicated as a key site affecting the expression of a cardiovirulent phenotype, differs from those predicted for cardiovirulent and pancreovirulent CVB3 strains. This is the first report characterizing a cloned CVB3 genome from an avirulent strain.
These authors contributed equally to this work.
The GenBank/EMBL/DDBJ accession number for the sequence reported in this paper is AY673831.
Present address: Department of Laboratory Medicine, Korea University Guro Hospital, Guro-gu Guro-dong 80, 152-050 Seoul, Republic of Korea.
This article has been cited by other articles:

|
 |

|
 |
 
R. Feuer, C. M. Ruller, N. An, J. M. Tabor-Godwin, R. E. Rhoades, S. Maciejewski, R. R. Pagarigan, C. T. Cornell, S. J. Crocker, W. B. Kiosses, et al.
Viral Persistence and Chronic Immunopathology in the Adult Central Nervous System following Coxsackievirus Infection during the Neonatal Period
J. Virol.,
September 15, 2009;
83(18):
9356 - 9369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-S. Kim, N. M. Chapman, and S. Tracy
Replication of Coxsackievirus B3 in Primary Cell Cultures Generates Novel Viral Genome Deletions
J. Virol.,
February 15, 2008;
82(4):
2033 - 2037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Si, Y. Wang, J. Wong, J. Zhang, B. M. McManus, and H. Luo
Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication
J. Virol.,
April 1, 2007;
81(7):
3142 - 3150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Bailey and W. E. Tapprich
Structure of the 5' Nontranslated Region of the Coxsackievirus B3 Genome: Chemical Modification and Comparative Sequence Analysis
J. Virol.,
January 15, 2007;
81(2):
650 - 668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kanno, K. Kim, K. Kono, K. M. Drescher, N. M. Chapman, and S. Tracy
Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
J. Virol.,
June 1, 2006;
80(11):
5637 - 5643.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the Society for General Microbiology.